These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 26680360)
1. A Novel Anti-Inflammatory Effect for High Density Lipoprotein. Cameron SJ; Morrell CN; Bao C; Swaim AF; Rodriguez A; Lowenstein CJ PLoS One; 2015; 10(12):e0144372. PubMed ID: 26680360 [TBL] [Abstract][Full Text] [Related]
2. Postprandial lipoproteins and the molecular regulation of vascular homeostasis. Botham KM; Wheeler-Jones CP Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609 [TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein and apolipoprotein A-I inhibit palmitate-induced translocation of toll-like receptor 4 into lipid rafts and inflammatory cytokines in 3T3-L1 adipocytes. Yamada H; Umemoto T; Kawano M; Kawakami M; Kakei M; Momomura SI; Ishikawa SE; Hara K Biochem Biophys Res Commun; 2017 Mar; 484(2):403-408. PubMed ID: 28137586 [TBL] [Abstract][Full Text] [Related]
4. Ceramide triggers Weibel-Palade body exocytosis. Bhatia R; Matsushita K; Yamakuchi M; Morrell CN; Cao W; Lowenstein CJ Circ Res; 2004 Aug; 95(3):319-24. PubMed ID: 15217913 [TBL] [Abstract][Full Text] [Related]
5. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Murphy AJ; Woollard KJ; Suhartoyo A; Stirzaker RA; Shaw J; Sviridov D; Chin-Dusting JP Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1333-41. PubMed ID: 21474825 [TBL] [Abstract][Full Text] [Related]
6. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247 [TBL] [Abstract][Full Text] [Related]
7. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Schultz JR; Verstuyft JG; Gong EL; Nichols AV; Rubin EM Nature; 1993 Oct; 365(6448):762-4. PubMed ID: 8413656 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Patel S; Di Bartolo BA; Nakhla S; Heather AK; Mitchell TW; Jessup W; Celermajer DS; Barter PJ; Rye KA Atherosclerosis; 2010 Oct; 212(2):392-7. PubMed ID: 20609437 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-I enhances proliferation of human endothelial progenitor cells and promotes angiogenesis through the cell surface ATP synthase. González-Pecchi V; Valdés S; Pons V; Honorato P; Martinez LO; Lamperti L; Aguayo C; Radojkovic C Microvasc Res; 2015 Mar; 98():9-15. PubMed ID: 25445031 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes. Maïga SF; Kalopissis AD; Chabert M Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775 [TBL] [Abstract][Full Text] [Related]